Intelligent Bio Solutions (INBS) EBIT (2019 - 2025)

Intelligent Bio Solutions' EBIT history runs 7 years deep, the most recent figure standing at -$2.6 million for Q1 2025.

• In Q1 2025, EBIT rose 13.32% year-over-year to -$2.6 million; the TTM figure through Mar 2025 stood at -$10.4 million (down 1.85% YoY), while the FY2024 annual figure was -$10.3 million, up 18.36% from the prior year.
• EBIT was -$2.6 million for Q1 2025 at Intelligent Bio Solutions, down from -$2.3 million in the prior quarter.
• In the past five years, EBIT ranged from a high of -$852646.0 in Q2 2021 to a low of -$6.5 million in Q1 2023.
• Historically, EBIT has averaged -$2.5 million across 5 years, with a median of -$2.5 million in 2023.
• The sharpest annual moves came in 2021 and 2022: EBIT sank 10795.49% in 2021, then soared 57.24% in 2022.
• A 5-year view of EBIT shows it stood at -$3.5 million in 2021, then jumped by 38.53% to -$2.1 million in 2022, then advanced by 6.55% to -$2.0 million in 2023, then slipped by 13.72% to -$2.3 million in 2024, then declined by 13.06% to -$2.6 million in 2025.
• The last three EBIT figures came in at -$2.6 million (Q1 2025), -$2.3 million (Q4 2024), and -$2.7 million (Q3 2024), per Business Quant data.